Company Critical Outcome Technologies Inc. Other OTC
Equities
CA22675B1031
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 31/12/14 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 11/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 30/06/18 | |
John C. Drake
CHM | Chairman | - | 19/02/07 |
Alison D. Silva
PSD | President | 46 | 31/12/14 |
David Sanderson
BRD | Director/Board Member | - | 04/12/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,986,415 | 15,211,245 ( 69.18 %) | 0 | 69.18 % |
Company contact information
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
Sector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |